Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “18F-PSMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05009979
What this trial is testing

18F-DCFPyL PET/CT in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Cancer Institute (NCI) 8
Not applicableActive Not RecruitingNCT02899312
What this trial is testing

PSMA PET/CT for Assessment of Recurrent Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstate Cancer
British Columbia Cancer Agency 2,244
Large-scale testing (Phase 3)UnknownNCT03344822
What this trial is testing

Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Central Hospital, Nancy, France 33
Not applicableLooking for participantsNCT06242119
What this trial is testing

Clinical Application of the J-PET Scanner Prototype

Who this might be right for
Prostate CancerProstatic HyperplasiaProstatic Neoplasms+3 more
Jagiellonian University 25
Not applicableNot Yet RecruitingNCT07485881
What this trial is testing

18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients

Who this might be right for
Prostate CancerProstate Cancer MetastaticProstate Cancer Recurrent
Assiut University 59
Not applicableUnknownNCT03507595
What this trial is testing

Evaluation of the Metastasis and Recurrence of Prostate Cancer

Who this might be right for
Prostate Cancer (Diagnosis)Prostate Cancer MetastaticProstate Cancer Recurrent+1 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 400
Not applicableStudy completedNCT02856100
What this trial is testing

Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 18
Not applicableStudy completedNCT03693742
What this trial is testing

MSG Use With 18F-DCFPyL PET/CT Imaging

Who this might be right for
Prostate CancerProstate Cancer MetastaticProstatic Neoplasm
British Columbia Cancer Agency 10
Testing effectiveness (Phase 2)WithdrawnNCT05815316
What this trial is testing

18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer

Who this might be right for
Prostate Cancer
IRCCS San Raffaele
Not applicableLooking for participantsNCT06450548
What this trial is testing

Dynamic 68Ga-PSMA and 18F-FDG PET/CT Analysis Prior to 177Lu-PSMA

Who this might be right for
Prostate Cancer Metastatic
Centre Henri Becquerel 60
Testing effectiveness (Phase 2)Ended earlyNCT04461509
What this trial is testing

High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy

Who this might be right for
Prostatic NeoplasmsGenital Neoplasms, MaleUrogenital Neoplasms+4 more
Alessandro D'Agnolo 62
Large-scale testing (Phase 3)Study completedNCT03911310
What this trial is testing

[18F]PSMA-11 PET/CT Phase 3 Clinical Study

Who this might be right for
Prostate Cancer
University Hospital, Ghent 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT03471650
What this trial is testing

Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 150
Testing effectiveness (Phase 2)Ended earlyNCT05712174
What this trial is testing

[18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer

Who this might be right for
OncologyProstate Cancer
AHS Cancer Control Alberta 176
Very early researchUnknownNCT02691169
What this trial is testing

Integrated 18F-labelled PSMA Project

Who this might be right for
Prostate Cancer
St. Joseph's Healthcare Hamilton 10
Not applicableLooking for participantsNCT06770478
What this trial is testing

Evaluate the Diagnostic Efficacy of 68Ga- MY6349 PET/CT in Patients With Tumours

Who this might be right for
Tumour of Epithelial Origin68Ga-MY6349
Xijing Hospital 40
Not applicableNot Yet RecruitingNCT07386496
What this trial is testing

The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI

Who this might be right for
Prostate Cancer
Chinese University of Hong Kong 250
Early research (Phase 1)Study completedNCT03995888
What this trial is testing

Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate Cancer

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 24
Not applicableLooking for participantsNCT06859203
What this trial is testing

A Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative or Inconclusive PSMA-ligand PET

Who this might be right for
Biochemical Recurrence of Malignant Neoplasm of Prostate
Technical University of Munich 94
Very early researchStudy completedNCT06520449
What this trial is testing

68Ga-NTA-476 Imaging in Prostate Cancer

Who this might be right for
Prostate Cancer
Melbourne Theranostic Innovation Centre 10
Next Page